021Igan17001
Research payments
$3,603,107
Through program year 2024, $3,603,107 in research payments was reported against 021Igan17001, across 2,530 payments, paid by Retrophin, Inc..
- Paid by
- Retrophin, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $537,516 | 433 |
| 2023 | Research | $367,309 | 278 |
| 2022 | Research | $134,527 | 83 |
| 2021 | Research | $1,733,571 | 1,128 |
| 2020 | Research | $476,361 | 395 |
| 2019 | Research | $353,823 | 213 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
6 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.